Malin-backed US drug firm tipped for €1bn sale

US drug development firm Poseida Therapeutics - of which State-backed investor Malin owns approximately 25% - has been tipped by analysts to fetch €1bn by way of a takeover next year.

San Diego-based Poseida is a clinical trial-stage company working on treatments for various blood-based cancers and solid tumors.